Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection.
BACKGROUND: Buruli ulcer (BU) is a neglected necrotizing disease of the skin, subcutaneous tissue and bone, caused by Mycobacterium ulcerans. BU pathogenesis is associated with mycolactone, a lipidic exotoxin with cytotoxic and immunosuppressive properties. Since 2004, the World Health Organization...
Main Authors: | Teresa G Martins, José B Gama, Alexandra G Fraga, Margarida Saraiva, Manuel T Silva, António G Castro, Jorge Pedrosa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3290623?pdf=render |
Similar Items
-
Corticosteroid-induced immunosuppression ultimately does not compromise the efficacy of antibiotherapy in murine Mycobacterium ulcerans infection.
by: Teresa G Martins, et al.
Published: (2012-01-01) -
Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model.
by: Gabriela Trigo, et al.
Published: (2013-01-01) -
Spontaneous Healing of Mycobacterium ulcerans Lesions in the Guinea Pig Model.
by: Rita Silva-Gomes, et al.
Published: (2015-12-01) -
Repurposing of statins for Buruli Ulcer treatment: antimicrobial activity against Mycobacterium ulcerans
by: Juan Dominguez, et al.
Published: (2023-09-01) -
Mycobacterium ulcerans disease
by: Tjip S. van der Werf, et al.